Angiogenic imbalance in pre‐eclampsia and fetal growth restriction: enhanced soluble fms‐like tyrosine kinase‐1 binding or diminished production of placental growth factor?-Reference-Cited by-同舟云学术

Angiogenic imbalance in pre‐eclampsia and fetal growth restriction: enhanced soluble fms‐like tyrosine kinase‐1 binding or diminished production of placental growth factor?

Published:2023-04 Issue:4 Volume:61 Page:466-473
ISSN:0960-7692
Container-title:Ultrasound in Obstetrics & Gynecology
language:en
Short-container-title:Ultrasound in Obstet & Gyne

Author:

Kluivers A. C. M.¹²^ORCID,Biesbroek A.¹²,Visser W.¹²,Saleh L.¹^ORCID,Russcher H.³,Danser A. H. J.¹,Neuman R. I.¹²^ORCID

Affiliation:

1. Department of Internal Medicine, Division of Pharmacology and Vascular Medicine Erasmus MC University Hospital Rotterdam The Netherlands

2. Department of Gynecology and Obstetrics Erasmus MC University Hospital Rotterdam The Netherlands

3. Department of Clinical Chemistry Erasmus MC University Hospital Rotterdam The Netherlands

Publisher

Wiley

Subject

Obstetrics and Gynecology,Radiology, Nuclear Medicine and imaging,Reproductive Medicine,General Medicine,Radiological and Ultrasound Technology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/uog.26088

Reference32 articles.

1. The Global Impact of Pre-eclampsia and Eclampsia

2. Pre-eclampsia

3. Pre-eclampsia: its pathogenesis and pathophysiolgy

4. Angiogenic Markers Predict Pregnancy Complications and Prolongation in Preeclampsia

5. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maternal serum PlGF associates with 3D power doppler ultrasound markers of utero-placental vascular development in the first trimester: the rotterdam periconception cohort;Angiogenesis;2024-08-14

2. The value of angiogenetic biomarkers in the detection of early onset fetal growth restriction;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-08

3. Tumor Necrosis Factor Inhibitor Use Increases Birthweight in Pregnant Women With Rheumatoid Arthritis Independently of the Soluble Fms‐Like Tyrosine Kinase‐1/Placental Growth Factor Ratio;Journal of the American Heart Association;2024-04-02

4. Systematic development of ionizable lipid nanoparticles for placental mRNA delivery using a design of experiments approach;Bioactive Materials;2024-04

5. Impact of adverse pregnancy outcomes on brain vascular health and cognition;Research and Practice in Thrombosis and Haemostasis;2024-01